UNICREDIT BANK/CALL/NOVO-NORDISK B/1150/0.1/18.09.24 Share Price

Warrant

DE000HD4FHQ9

Market Closed - BOERSE MUENCHEN 20:46:36 31/05/2024 BST
0.14 EUR -.--% Intraday chart for UNICREDIT BANK/CALL/NOVO-NORDISK B/1150/0.1/18.09.24
1 month-33.33%
Date Price Change
31/05/24 0.14 -.--%
30/05/24 0.14 +7.69%
29/05/24 0.13 -7.14%
28/05/24 0.14 -6.67%
27/05/24 0.15 -6.25%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 08:46 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer UniCredit UniCredit
WKN HD4FHQ
ISINDE000HD4FHQ9
Date issued 08/04/2024
Strike 1,150 kr
Maturity 18/09/2024 (109 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.26
Lowest since issue 0.099
Delta0x
Omega 0.000000
Premium0x
Gearing85.66x
Moneyness 0.8063
Difference Strike 222.7 kr
Difference Strike %+19.37%
Spread 0.07
Spread %38.89%
Intrinsic value 0.000000
Present value 0.1400

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3 DKK
Average target price
917.2 DKK
Spread / Average Target
-1.09%
Consensus